Market Trends And Opportunities In Global Ulcerative Colitis Market Up To 2022 – Report By Market Data Forecast

Market Trends And Opportunities In Global Ulcerative Colitis Market Up To 2022 – Report By Market Data Forecast

ID: 6450 | October 2018 | Region: Global


The Ulcerative Colitis Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Ulcerative Colitis Market is estimated to be USD 5.1 billion in 2017 and predicted to rise to USD 7.05 billion by 2022 with a CAGR of 6.7%. The market is segmented by Product (Monoclonal Antibodies, Biosimilars and Pharmaceuticals), by Type (Proctosigmoiditis, Ulcerative Proctitis, Pancolitis and Left sided Colitis) and by Route of Administration (Oral and Injectable). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Due to the changing lifestyles of people with unhealthy diets, prevalence of ulcerative colitis has increased. Increase in investments in pharmaceutical industries for the development of novel drugs, growing risk of acquiring colon cancer and growing healthcare expenditure are expected to propel the market growth. However, strict regulations on product approvals especially biosimilars and chances of recurrence of the disease are hindering the market growth.

Based on product, Biosimilars hold the largest market share due to their high production in the last decade due to the patent expiration of branded drugs. Monoclonal antibodies segment is the fastest growing segment due to their effectiveness at curing the disease. By type, Proctosigmoiditis is the most common type of ulcerative colitis and hence it holds the major market share.

North America leads the global market for ulcerative colitis. North America is the host for a large number of research activities in the drug development and also has numerous pharmaceutical companies. Asia Pacific is expected to be the fastest growing market. It is due to the developing healthcare sector in emerging countries such as India through government intervention and expansions of major pharmaceutical companies to this region.

Some of the major players in Ulcerative Colitis market are Abbott Laboratories, GlaxoSmithKline, Pfizer, Takeda Pharmaceuticals, AbbVie, Johnson and Johnson, Merck, Sanofi, F. Hoffmann-La Roche and Shire Pharmaceuticals.

Browse through the full report at https://www.marketdataforecast.com/market-reports/ulcerative-colitis-market-6438/ and checkout our recent reports in the Therapeutics at https://www.marketdataforecast.com/subcategory/therapeutics-11/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.